Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK charity slams high rates of late diagnoses of lung cancer

This article was originally published in Clinica

Executive Summary

UK cancer charity Macmillan Cancer Relief (MCR) has greeted the latest national mortality statistics with calls for the earlier diagnosis of lung cancer. 80% of lung cancer cases are inoperable due to their late diagnosis, according to the charity. "If people were diagnosed at a much earlier stage, it would be possible for many more of them to have an operation that could potentially cure their cancer," said MCR chief executive Peter Cardy. Cancer of the trachea, bronchus and lung was the third leading cause of death in males (7.5%), and sixth in females (4.5%), in England and Wales in 2005, according to the Office of National Statistics.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051845

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel